Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Japanese Journal of Cancer and Chemotherapy is Scopus-indexed (Q4, CiteScore 0.1). Published by Japanese Journal of Cancer and Chemotherapy Publishers Inc..
Checked against the index lists dated .
ISSN 0385-0684Verify ISSN ↗
Publisher: Japanese Journal of Cancer and Chemotherapy Publishers Inc.
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Oncology | 413 / 428 | 3rd | Q4 |
| Cancer Research | 229 / 233 | 1st | Q4 |
Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1979–present, best quartile Q4, CiteScore 0.1.
Japanese Journal of Cancer and Chemotherapy is Q4 in Oncology (rank 413 of 428) and Q4 in Cancer Research (rank 229 of 233), by CiteScore 2025.
Japanese Journal of Cancer and Chemotherapy is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 0.1, quartile Q4, 3rd percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.118, quartile Q4, with an H-index of 27.
Japanese Journal of Cancer and Chemotherapy is published by Japanese Journal of Cancer and Chemotherapy Publishers Inc. Its ISSN is 0385-0684.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
No — it is not registered as an open-access journal in DOAJ or Scopus.
Japanese Journal of Cancer and Chemotherapy has an h-index of 5 and a 2-year mean of 0 citations per paper (OpenAlex). Its Scopus CiteScore is 0.1, quartile Q4. On 2-year citations it ranks #402 of 424 Scopus journals in Oncology.
Japanese Journal of Cancer and Chemotherapy published 120 papers in 2021; its busiest recent year was 2019 with 372. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 80 research articles (2021), authors are most often from Japan (100%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.